pityriasis%20(tinea)%20versicolor%20(pediatric)
PITYRIASIS (TINEA) VERSICOLOR (PEDIATRIC)
Pityriasis (tinea) versicolor is a benign, superficial, common fungal infection localized to the stratum corneum.
It occurs most commonly in postpubertal individuals when the sebaceous glands are the most active.
Facial involvement is common in adolescents, but lesions are also found on the upper trunk, neck, arms, dorsum of the hand and pubis.
Patient presents with erythematous, hypo- or hyperpigmented macules or patches that may have a slight scale.
It is caused by the lipophilic yeast Malassezia furfur.

Definition

  • Common, benign, superficial fungal infection localized to the stratum corneum
    • Occurs most commonly in postpubertal individuals when the sebaceous glands are the most active

Etiology

  • Caused by lipophilic yeast Malassezia spp & M. furfur is the most common

Signs and Symptoms

  • Facial involvement is common in adolescents, but lesions are also found on the upper trunk, neck, arms, dorsum of the hand & pubis
    • Although sometimes it is generalized
  • Patient presents w/ erythematous, hypo- or hyperpigmented macules or patches that may have a slight scale
    • Pruritus may or may not be present
  • Lesions do not tan along w/ surrounding normal skin

Risk Factors

Factors that Promote Tinea Versicolor Infection:

  • High temperature & high humidity
    • Prominent in tropical & subtropical regions
  • Occlusive clothing
  • Oily skin
  • Application of oils to skin
  • Excessive sweating
  • Immunocompromise conditions, malnutrition & hereditary predisposition
  • High levels of plasma cortisol
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
09 Apr 2016
Among adolescents who have only received diphtheria, tetanus toxoids, acellular pertussis (DTaP) vaccines in childhood, tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine provides moderate protection against pertussis during the first year and then wanes rapidly thereafter.
26 Jul 2007
Despite the prevalence of corticosteroid use in infants with bronchiolitis, data on its efficacy is insufficient. In this study, oral dexamethasone was compared with placebo in the treatment of bronchiolitis.